Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
16 studies found for:    Diindolylmethane
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: B-Dim;   Procedure: Radical Prosatectomy
2 Completed Diindolylmethane in Healthy Volunteers
Condition: Healthy, no Evidence of Disease
Intervention: Drug: oral microencapsulated diindolylmethane
3 Withdrawn Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
Condition: Breast Cancer Female
Interventions: Drug: oral microencapsulated diindolylmethane;   Other: laboratory biomarker analysis
4 Active, not recruiting Diindolylmethane in Treating Patients With Breast Cancer
Conditions: Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Dietary Supplement: diindolylmethane;   Dietary Supplement: placebo
5 Completed Diindolylmethane in Preventing Cancer in Healthy Volunteers
Condition: Healthy, no Evidence of Disease
Interventions: Drug: diindolylmethane;   Other: placebo;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
6 Unknown  The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Condition: Breast Cancer
Intervention: Dietary Supplement: Diindolylmethane (DIM)
7 Completed Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
Condition: Prostate Cancer
Intervention: Drug: BR-DIM
8 Completed Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Prostate Cancer;   Stage I Prostate Cancer;   Stage II Prostate Cancer
Interventions: Drug: diindolylmethane;   Drug: placebo;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Terminated 3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus
Condition: SLE
Interventions: Drug: BR-DIM;   Drug: Placebo
10 Completed Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
Condition: Cervical Dysplasia
Interventions: Drug: di indolylmethane (DIM);   Dietary Supplement: Red rice bran
11 Completed Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Drug: oral microencapsulated diindolylmethane;   Genetic: polymerase chain reaction;   Other: cervical Papanicolaou test;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy
12 Completed Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio
Condition: Breast Cancer
Interventions: Dietary Supplement: DIM pills;   Other: Placebo Pill
13 Not yet recruiting Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study
Conditions: Kidney Diseases;   Cardiovascular Diseases
Interventions: Dietary Supplement: Commercially available Diindolylmethane;   Other: Placebo
14 Terminated
Has Results
New Therapy of Laryngeal Papilloma In Children
Condition: Papilloma
Interventions: Dietary Supplement: diindolylmethane (DIM);   Device: 585 nm pulsed dye laser
15 Terminated DIM as a Treatment for Thyroid Disease
Condition: Proliferative Thyroid Disease
Intervention: Dietary Supplement: Diindolylmethane (DIM)
16 Recruiting A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers
Conditions: BRCA1 Gene Mutation;   BRCA2 Gene Mutation
Intervention: Dietary Supplement: DIM-Avail 100mg

Study has passed its completion date and status has not been verified in more than two years.